Literature DB >> 1991007

Diagnostic and therapeutic considerations for cutaneous Mycobacterium haemophilum infections.

M E McBride, A H Rudolph, J A Tschen, P Cernoch, J Davis, B A Brown, R J Wallace.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1991007

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  10 in total

Review 1.  Agents of newly recognized or infrequently encountered mycobacterial diseases.

Authors:  L G Wayne; H A Sramek
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

Review 2.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

3.  Mycobacterium haemophilum as a novel etiology of cervical lymphadenitis in an otherwise healthy adult patient.

Authors:  Theobald J C Minani; Michael A Saubolle; Edwin Yu; Zdenek Sussland
Journal:  J Clin Microbiol       Date:  2010-05-19       Impact factor: 5.948

Review 4.  Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans.

Authors:  M A Saubolle; T E Kiehn; M H White; M F Rudinsky; D Armstrong
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

Review 5.  Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infections.

Authors:  Jerome A Lindeboom; Lesla E S Bruijnesteijn van Coppenraet; Dick van Soolingen; Jan M Prins; Eduard J Kuijper
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

Review 6.  Mycobacterium haemophilum: an emerging pathogen.

Authors:  T E Kiehn; M White
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

7.  Biochemical properties and fatty acid composition of Mycobacterium haemophilum: study of 16 isolates from Australian patients.

Authors:  F Portaels; D J Dawson; L Larsson; L Rigouts
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

8.  Activities of antimicrobial agents against clinical isolates of Mycobacterium haemophilum.

Authors:  E M Bernard; F F Edwards; T E Kiehn; S T Brown; D Armstrong
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

9.  Treatment of Mycobacterium haemophilum infection in a murine model with clarithromycin, rifabutin, and ciprofloxacin.

Authors:  B A Atkinson; R Bocanegra; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

10.  A cluster of four cases of Mycobacterium haemophilum infection.

Authors:  T E Kiehn; M White; K J Pursell; N Boone; M Tsivitis; A E Brown; B Polsky; D Armstrong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-02       Impact factor: 3.267
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.